Cargando…
The diagnostic role of cardiac magnetic resonance used “first and last time in life” in a patient with a suspected dilated phase of hypertrophic cardiomyopathy
Autores principales: | Hładij, Rafał, Rajtar-Salwa, Renata, Dziewierz, Artur, Petkow-Dimitrow, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545661/ https://www.ncbi.nlm.nih.gov/pubmed/28798793 http://dx.doi.org/10.5114/pwki.2017.68049 |
Ejemplares similares
-
Anginal pain and elevated troponin level despite normal coronary angiography: hypertrophic cardiomyopathy with severe obstruction due to vasodilator/diuretic therapy for coincident arterial hypertension
por: Gębka, Adam, et al.
Publicado: (2018) -
Role of cardiac magnetic resonance in differentiating between acute coronary syndrome and apical hypertrophic cardiomyopathy
por: Rajtar-Salwa, Renata, et al.
Publicado: (2016) -
Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014)
por: Hładij, Rafał, et al.
Publicado: (2017) -
Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014
por: Rajtar-Salwa, Renata, et al.
Publicado: (2017) -
Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy
por: Gębka, Adam, et al.
Publicado: (2020)